Ruizhi Pharmaceutical (300149.SZ) subsidiary plans to invest RMB 10 million in Wuhan Bainuo Jiatai Venture Capital Partnership

Zhitong Finance APP News, Ruizhi Pharmaceutical (300149.SZ) announced that its wholly-owned subsidiary Beihai Ruizhi Venture Capital Co., Ltd. (hereinafter referred to as "Beihai Ruizhi") recently signed the "Wuhan Bainuo Jiatai Venture Capital Partnership (Limited Partnership) Partnership Agreement" with professional investment institution Shanghai Bainuo Private Fund Management Co., Ltd. (hereinafter referred to as "Bainuo Capital") and other limited partners. Beihai Ruizhi, as a limited partner, plans to use its own funds of 10 million yuan to increase its capital contribution to Wuhan Bainuo Jiatai Venture Capital Partnership (Limited Partnership) (hereinafter referred to as "Bainuo Jiatai"), accounting for 29.24% of the partnership's total subscribed capital contribution.